steer study semaglutide vs TIRZEPATIDE 2⃣drugs 2⃣different trial design 2⃣different results Take on account doses, populations, endpoints, follow-up, 📌STEER-Overweight/obesity & ASCVD with/without DM 📌SURMOUNT-5 Obesity without DM or ASCVD #ESCCongress Why cardiologists may prescribe semaglutide

Some have proposed that increasing cerebral blood flow using HBOT could improve brain health

Publisher | Google Scholor Silva YP, Bernardi A, Frozza RL

These findings suggest the potential for substantial glycaemic improvement in certain individuals, though results from a single phase 2 trial should be interpreted cautiously

22:e00712

BPC-157 for Sports Injuries: What a Systematic Review of the Evidence Actually Shows. HSS journal : the musculoskeletal journal of Hospital for Special Surgery.Study breakdown PubMed 2RPEP-12503McGuire, Flynn P et al

These are typically administered via subcutaneous injection at standard therapeutic doses as recommended in the manufacturer's Summary of Product Characteristics (SmPC) and regulatory bodies such as the MHRA